Clinical and genetic associations of autoantibodies to 3‐hydroxy‐3‐methyl‐glutaryl‐coenzyme a reductase in patients with immune‐mediated myositis and necrotizing myopathy

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Muscle and Nerve

• Publication date

  2015-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/mus.24541PMID 25521389
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• R: A language and environment for statistical computing.

  2014cited by this paper
• The spectrum of statin myopathy

  2013influential reference
• The incidence and associations of malignancy in a large cohort of patients with biopsy-determined idiopathic inflammatory myositis

  2013cited by this paper
• Review: Immune‐mediated necrotizing myopathies – a heterogeneous group of diseases with specific myopathological features

  2012cited by this paper
• Antibody Levels Correlate with Creatine Kinase Levels and Strength in Anti-HMG-CoA Reductase-Associated Autoimmune Myopathy

  2012cited by this paper
• A three-way interplay of DR4, autoantibodies and synovitis in biopsy-proven idiopathic inflammatory myositis

  2012cited by this paper
• Increased frequency of DRB1*11:01 in anti–hydroxymethylglutaryl‐coenzyme A reductase–associated autoimmune myopathy

  2012cited by this paper
• Necrotizing myopathy: Clinicoserologic associations

  2012cited by this paper
• Rarity of anti–3‐hydroxy‐3‐methylglutaryl‐coenzyme A reductase antibodies in statin users, including those with self‐limited musculoskeletal side effects

  2012cited by this paper
• Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy.

  2012cited by this paper
• Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy.

  2011cited by this paper
• Necrotizing autoimmune myopathy

  2011cited by this paper
• Pathophysiology of inflammatory and autoimmune myopathies.

  2011cited by this paper
• Inflammatory or necrotizing myopathies, myositides and other acquired myopathies, new insight in 2011.

  2011cited by this paper
• A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy.

  2010cited by this paper
• Immune‐mediated necrotizing myopathy associated with statins

  2010cited by this paper
• Immune-Mediated Necrotizing Myopathy Associated with Statins

  2010cited by this paper
• Idiopathic inflammatory myositis is associated with a high incidence of hypertension and diabetes mellitus

  2010cited by this paper
• Idiopathic inflammatory myopathies

  2009cited by this paper
• Steroid-Responsive Myopathy: Immune-Mediated Necrotizing Myopathy or Polymyositis Without Inflammation?

  2008cited by this paper
• Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM

  2008cited by this paper
• Newly identified autoantibodies: relationship to idiopathic inflammatory myopathy subsets and pathogenesis

  2008cited by this paper
• Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes

  2007cited by this paper
• Progressive myopathy with up-regulation of MHC-I associated with statin therapy.

  2007cited by this paper
• Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy.

  2007cited by this paper
• The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis

  2007cited by this paper
• Immunogenetic Risk and Protective Factors for the Idiopathic Inflammatory Myopathies: Distinct HLA-A, -B, -Cw, -DRB1, and -DQA1 Allelic Profiles Distinguish European American Patients With Different Myositis Autoantibodies

  2006cited by this paper
• Clinical implications of autoantibody screening in patients with autoimmune myositis

  2006cited by this paper
• A novel autoantibody to a 155-kd protein is associated with dermatomyositis.

  2006cited by this paper
• Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy

  2005cited by this paper
• 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands.

  2004cited by this paper
• Have recent immunogenetic investigations increased our understanding of disease mechanisms in the idiopathic inflammatory myopathies?

  2004cited by this paper
• Necrotising myopathy, an unusual presentation of a steroid-responsive myopathy

  2003cited by this paper
• Idiopathic inflammatory myopathies: epidemiology, classification, and diagnostic criteria.

  2002cited by this paper
• Differences in idiopathic inflammatory myopathy phenotypes and genotypes between Mesoamerican Mestizos and North American Caucasians: ethnogeographic influences in the genetics and clinical expression of myositis.

  2002cited by this paper
• HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis

  2002cited by this paper
• Incidence of Malignant Disease in Biopsy-Proven Inflammatory Myopathy: A Population-Based Cohort Study

  2001cited by this paper
• Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study.

  2001cited by this paper
• 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and the risk of cancer: a nested case-control study.

  2000cited by this paper
• Humoral immunity in polymyositis/dermatomyositis.

  1993cited by this paper
• Importance of mevalonate‐derived products in the control of HMG‐CoA reductase activity and growth of human lung adenocarcinoma cell line a549

  1993cited by this paper
• Increase in the active form of 3-hydroxy-3-methylglutaryl coenzyme A reductase in human hepatocellular carcinoma: possible mechanism for alteration of cholesterol biosynthesis.

  1990cited by this paper

• Clinical-pathologic classification of anti-HMGCR-positive immune-mediated necrotizing myopathy

  2025cites this paper
• Genetic Biomarkers for Statin-Induced Myopathy

  2025cites this paper
• Immune-mediated necrotizing myopathy: an emerging disorder.

  2025cites this paper
• The incidence of anti-HMGCR immune-mediated necrotizing myopathy: an Australian and UK retrospective multi-site cohort study

  2025cites this paper
• Remission of Statin-associated Autoimmune Necrotizing Myopathy With Sequential Immunotherapy: A Well-studied Patient

  2025cites this paper
• Updates in the Management of Immune-Mediated Necrotizing Myopathy.

  2025cites this paper
• Anti-HMGCR myopathy: Diversity of clinical presentations in a national cohort in New Zealand.

  2024cites this paper
• Breaking Down Statin Myopathy: Understanding the Self-Limited and Autoimmune Subtypes.

  2024cites this paper
• Diffuse Large B-cell Lymphoma Complicated with Anti-3-hydroxy-3-methylglutaryl-Coenzyme A Reductase Immune-mediated Necrotizing Myopathy

  2024cites this paper
• Miopatía necrosante inmunomediada: experiencia en una unidad neuromuscular

  2024cites this paper
• Precise identification and tracking of HMGCR-reactive CD4+ T cells in the target tissue of patients with anti-HMGCR immune-mediated necrotising myopathy

  2024cites this paper
• The first reported familial case of statin-induced immune-mediated necrotizing myopathy associated with anti-hydroxy-3-methylglutaryl-CoA reductase autoantibodies and HLA DRB1*11:01

  2024cites this paper
• Absence of Pathogenic Mutations and Strong Association With HLA-DRB1*11:01 in Statin-Naïve Early-Onset Anti-HMGCR Necrotizing Myopathy

  2024cites this paper
• Distinct phenotype and prognosis of immune-mediated necrotizing myopathy based on clinical-serological-pathological classification.

  2024cites this paper
• Statin-Induced Immune-Mediated Necrotizing Myopathy Resulting in Proximal Muscle Weakness

  2023cites this paper
• Anti-SRP-positive necrotising myopathy concurrent with breast malignancy

  2023cites this paper
• Dysphagia: A Case Report of an Atypical Presentation of Statin-Induced Necrotizing Myositis

  2023cites this paper
• Cancer and idiopathic inflammatory myopathies –association of autoantibodies with carcinogenesis

  2023cites this paper
• Anti-HMGCR immune-mediated necrotising myopathy: Addressing the remaining issues.

  2023cites this paper
• Current Biomarker Strategies in Autoimmune Neuromuscular Diseases

  2023cites this paper
• Epidemiology of the idiopathic inflammatory myopathies

  2023cites this paper
• Miopatías Necrotizantes Autoinmunes: Reconocimiento como nuevo subgrupo de Miopatía Inflamatoria Idiopática

  2023cites this paper
• Chronic Anti-HMG-CoA Reductase Positive Necrotizing Myositis With Remote Exposure to Statins

  2023cites this paper
• Immune-Mediated Necrotizing Myositis with Hydroxy-3-Methyl-Glutaryl-Coenzyme a Reductase Antibody Positivity in MSA-Negative and Statin-Naive Profile

  2023cites this paper
• Pathogenesis and Treatment in IMNM

  2023cites this paper
• Pediatric immune-mediated necrotizing myopathy

  2023cites this paper
• Clinical and Radiological Features of Korean Patients With Anti-HMGCR Myopathy

  2023cites this paper
• Clinical associations of patients with anti–3‐hydroxy‐3‐methylglutaryl CoA reductase antibody–associated immune‐mediated necrotising myopathy

  2023cites this paper
• Environmental Risks for Inflammatory Myopathies.

  2022cites this paper
• Association of immune‐mediated necrotizing myopathy with HLA polymorphisms

  2022influential citation
• Anti-SRP immune-mediated necrotizing myopathy: A critical review of current concepts

  2022cites this paper
• Outcome predictors of immune-mediated necrotizing myopathy—a retrospective, multicentre study

  2022cites this paper
• Cancer and myositis: Who, when, and how to screen.

  2022cites this paper
• Autoantibodies against four-and-a-half-LIM domain 1 (FHL1) in inflammatory myopathies: results from an Australian single-centre cohort

  2022cites this paper
• Statin-associated muscle symptoms: Myth or reality?

  2022cites this paper
• Autoantibodies: Pathogenic or epiphenomenon.

  2022cites this paper
• Sintomatología muscular asociada a estatinas: ¿mito o realidad?

  2022cites this paper
• Epidemiological and genetic features of anti-3‑hydroxy-3-methylglutaryl-CoA reductase necrotizing myopathy: Single-center experience and literature review.

  2022cites this paper
• Autoantibody Markers of Increased Risk of Malignancy in Patients with Dermatomyositis

  2022cites this paper
• Bioinformatics Analysis of Gene Expression Profiles of Immune-mediated Necrotizing Myopathy

  2021cites this paper
• Anti-HMGCR myopathy: clinical and histopathological features, and prognosis

  2021cites this paper
• [A 81-year old man of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibody-positive myopathy associated with lung adenocarcinoma cancer].

  2021cites this paper
• Anti-HMGCR myopathy overlaps with dermatomyositis-like rash: a distinct subtype of idiopathic inflammatory myopathy

  2021cites this paper
• Detection of multiple myositis-specific autoantibodies in unique patients with idiopathic inflammatory myopathy: A single centre-experience and literature review: Systematic review.

  2021cites this paper
• Therapeutic Management of Immune-Mediated Necrotizing Myositis

  2021cites this paper
• Autoimmune necrotizing myositis. Presentation of a clinical case

  2021cites this paper
• The effects of HMG-CoA reductase inhibitors on disease activity in multiple sclerosis: A systematic review and meta-analysis.

  2021cites this paper
• Pharmacogenomics for Primary Care: An Overview

  2020cites this paper
• Immune-mediated necrotizing myopathy: clinical features and pathogenesis

  2020cites this paper
• Pharmacogenetics of Statin-Induced Myotoxicity

  2020cites this paper
• TCRM_A_197941 483..492

  2020cites this paper
• Statin Associated Autoimmune Myonecrosis: Case Report With Delayed Onset and Treatment Challenges

  2020influential citation
• Anti-HMGCR Myopathy: A Rare and Serious Side Effect of Statins

  2020cites this paper
• Risk Factors and Cancer Screening in Myositis.

  2020cites this paper
• Clinical and histological features of immune-mediated necrotising myopathy: A multi-centre South Australian cohort study.

  2020cites this paper
• Statin-Associated Muscle Disorders

  2020cites this paper
• Statins and autoimmunity: State-of-the-art.

  2020cites this paper
• Statin-associated anti-HMGCR immune-mediated necrotizing myopathy with dermatomyositis-like features: A case report

  2020cites this paper
• Statin-Associated Autoimmune Myopathy: Current Perspectives

  2020cites this paper
• Emerging Therapeutics in Idiopathic Inflammatory Myopathy

  2020cites this paper
• Statin-Related Myotoxicity: A Comprehensive Review of Pharmacokinetic, Pharmacogenomic and Muscle Components

  2019cites this paper
• Inflammatory Myopathies

  2019cites this paper
• Imaging in the diagnosis of idiopathic inflammatory myopathies; indications and utility

  2019cites this paper
• [Dermatomyositis-like syndrome revealing statin-induced necrotizing autoimmune myopathy with anti-HMGCR antibodies].

  2019cites this paper
• Immune-mediated necrotising myopathy: A critical review of current concepts.

  2019cites this paper
• Anti-SRP positive immune-mediated necrotic myopathy with two ulnar fingers on the right hand : a case report

  2019cites this paper
• The Role of Autoantibodies in Idiopathic Inflammatory Myopathies

  2019cites this paper
• Clinical spectrums and outcomes of necrotizing autoimmune myopathy versus other idiopathic inflammatory myopathies: a multicenter case-control study

  2019cites this paper
• External Validation and Evaluation of Adding MRI or Extended Myositis Antibody Panel to the 2017 EULAR/ACR Myositis Classification Criteria

  2019cites this paper
• [Clinical and pathological characteristics of immune mediated necrotizing myopathy].

  2019cites this paper
• Newly Described Myositis Autoantibodies: HMGCR, NT5C1A, SAE, PUF60

  2019cites this paper
• Immune-Mediated Necrotizing Myopathy (IMNM)

  2019cites this paper
• Statin‐associated immune‐mediated necrotising myopathy: a New Zealand case series showing possible overrepresentation in Pacific Islanders

  2018cites this paper
• Autoimmune Myopathies: Updates on Evaluation and Treatment

  2018cites this paper
• Anti-HMGCR Myopathy

  2018cites this paper
• Classification and management of adult inflammatory myopathies.

  2018cites this paper
• Association of Statin Exposure With Histologically Confirmed Idiopathic Inflammatory Myositis in an Australian Population

  2018cites this paper
• Author reply

  2018cites this paper
• Role of genetics in the prediction of statin-associated muscle symptoms and optimization of statin use and adherence

  2018cites this paper
• Triggers of inflammatory myopathy: insights into pathogenesis.

  2018cites this paper
• Immune-Mediated Necrotizing Myopathy

  2018cites this paper
• Clinico-serologic features of statin-induced necrotising autoimmune myopathy in a single-centre cohort

  2018cites this paper
• A review of inflammatory idiopathic myopathy focusing on polymyositis

  2018cites this paper
• Differenzialdiagnose der CK-Erhöhung

  2018cites this paper
• Differential Diagnosis of HyperCKemia

  2018cites this paper
• Pharmacogenetics and Pharmacogenomics in Cardiovascular Medicine and Surgery

  2018cites this paper
• Statin-induced myalgia and myositis: an update on pathogenesis and clinical recommendations

  2018cites this paper
• Myositis in clinical practice-relevance of new antibodies.

  2018cites this paper
• Statiny indukovaná nekrotizující autoimunitní myopatie Statin-induced Necrotiz ing Autoim mune Myopathy

  2018cites this paper
• Clinical significance of rare serum autoantibodies in rheumatic diseases: a systematic literature review

  2018cites this paper
• Association of Statin ExposureWith Histologically Confirmed Idiopathic InflammatoryMyositis in an Australian Population

  2018cites this paper
• Serious statin-associated myositis in an Australian Aboriginal man

  2017cites this paper
• Anti–3‐hydroxy‐3‐methylglutaryl‐coenzyme a reductase necrotizing myopathy masquerading as a muscular dystrophy in a child

  2017cites this paper
• 免疫介在性壊死性ミオパチー（IMNM）とHLA多型

  2017cites this paper
• New immunoassays for anti-HMG-CoA reductase antibodies may lead to incorrect diagnosis in inflammatory myositis.

  2017cites this paper
• Statin-associated muscle toxicity : clinical and genomic perspectives

  2017influential citation
• Inflammatory myopathies and human leukocyte antigen

  2017cites this paper
• Immune-mediated necrotizing myopathy

  2017cites this paper
• Anti-HMGCR Necrotizing Autoimmune Myopathy Leading to Identification of Cancer Relapse

  2017influential citation
• An Unusual Case of Statin-Related Myopathy

  2017cites this paper